| Literature DB >> 32032752 |
Giovanni Battista Migliori1, Simon Tiberi2, Alimuddin Zumla3, Eskild Petersen4, Jeremiah Muhwa Chakaya5, Christian Wejse6, Marcela Muñoz Torrico7, Raquel Duarte8, Jan Willem Alffenaar9, H Simon Schaaf10, Ben J Marais11, Daniela Maria Cirillo12, Riccardo Alagna13, Adrian Rendon14, Emanuele Pontali15, Alberto Piubello16, José Figueroa17, Gabriella Ferlazzo18, Alberto García-Basteiro19, Rosella Centis20, Dina Visca21, Lia D'Ambrosio22, Giovanni Sotgiu23.
Abstract
The continuous flow of new research articles on MDR-TB diagnosis, treatment, prevention and rehabilitation requires frequent update of existing guidelines. This review is aimed at providing clinicians and public health staff with an updated and easy-to-consult document arising from consensus of Global Tuberculosis Network (GTN) experts. The core published documents and guidelines have been reviewed, including the recently published MDR-TB WHO rapid advice and ATS/CDC/ERS/IDSA guidelines. After a rapid review of epidemiology and risk factors, the clinical priorities on MDR-TB diagnosis (including whole genome sequencing and drug-susceptibility testing interpretations) and treatment (treatment design and management, TB in children) are discussed. Furthermore, the review comprehensively describes the latest information on contact tracing and LTBI management in MDR-TB contacts, while providing guidance on post-treatment functional evaluation and rehabilitation of TB sequelae, infection control and other public health priorities.Entities:
Keywords: Diagnosis; MDR-TB; Prevention; Rehabilitation of sequelae; Treatment; XDR-TB
Mesh:
Year: 2020 PMID: 32032752 DOI: 10.1016/j.ijid.2020.01.042
Source DB: PubMed Journal: Int J Infect Dis ISSN: 1201-9712 Impact factor: 3.623